XML 80 R53.htm IDEA: XBRL DOCUMENT v3.23.3
Supplemental information - schedule of redeemable non-controlling interest (Details) - USD ($)
$ in Millions
12 Months Ended
Aug. 31, 2023
Aug. 31, 2022
Aug. 31, 2021
Increase (Decrease) in Temporary Equity [Roll Forward]      
Beginning balance $ 1,042 $ 319 $ 0
Recognition upon acquisition of subsidiary 0 2,684 309
Acquisitions of non-controlling interests 0 (2,047) 0
Net loss attributable to Redeemable non-controlling interests (21) (73) (3)
Redemption price adjustments 442 179 19
Reclassifications to accrued expenses and other liabilities (1,314) 0 0
Other 18 (20) (6)
Ending balance 167 1,042 319
Conversion of Stock [Line Items]      
Recognition upon acquisition of subsidiary $ 0 2,684 $ 309
VillageMD      
Increase (Decrease) in Temporary Equity [Roll Forward]      
Recognition upon acquisition of subsidiary   1,900  
Conversion of Stock [Line Items]      
Recognition upon acquisition of subsidiary   $ 1,900  
McKesson Corporation, GEHE Pharma Handel      
Conversion of Stock [Line Items]      
Outstanding equity interest percentage   30.00%